NDATOPICALSOLUTION
Approved
May 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
HALOG (halcinonide) by PharmaIN is corticosteroid hormone receptor agonists [moa]. First approved in 1977.
Drug data last refreshed 36m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HALOG (halcinonide) is a potent topical corticosteroid that acts as a corticosteroid hormone receptor agonist used to treat inflammatory skin conditions. Delivered as a topical solution, it binds to glucocorticoid receptors to reduce inflammation, itching, and dermatological symptoms. The product targets patients with steroid-responsive dermatoses including psoriasis, eczema, and other inflammatory skin disorders.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), suggesting a stable but shrinking commercial organization focused on defensive positioning rather than growth initiatives.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients
Started Mar 2026
90 enrolled
Deafness, Bilateral
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)
Started Nov 2025
94 enrolled
Depressive Disorder, Major
Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstruction With Fast Multipole Method
Started Jan 2025
30 enrolled
Healthy
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Started Jan 2024
99 enrolled
Cannabis UseAlcohol Use, Unspecified
Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
Started Oct 2023
0Sleep Disorder
Worked on HALOG at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.